Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
16.37 Down 0.37(2.21%) Apr 17, 4:00PM EDT
|After Hours : 16.37 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
Add to Portfolio
Prev Close:16.74
Open:16.58
Bid:N/A
Ask:17.46 x 100
1y Target Est:23.50
Beta:0.34
Next Earnings Date: 8-May-15OSIR Earnings announcement
Day's Range:16.28 - 16.72
52wk Range:11.80 - 18.86
Volume:150,774
Avg Vol (3m):138,540
Market Cap:562.34M
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIRDown 2.21%562.34M
ABTDown 0.58%69.79B
BIIBDown 2.15%98.41B

Key Statistics

Forward P/E (1 yr):27.28
P/S (ttm):9.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.31
Quarterly EPS Est (Mar-15) :0.00
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback